retatrutide approval status 2025 retatrutide fda approval HAS NOT BEEN APPROVED YET & CURRENTLY IN PHASE III CLINICAL TRIALS⛔️ is not currently FDA-approved, as it is in Phase III clinical trials with anticipated completion in 2025–2026 and Retatrutide Dosing Guide: 1-12 mg

If delivery can be demonstrated alongside biological activity, the case for rigorous wound healing trials strengthens considerably

The body doesn't want you to lose weight

Increases and restores telomere length: Peer-reviewed research has demonstrated Epithalons ability to induce telomere elongation in human somatic cells

doi:10.4022/jafib.2205

It's a matter of personal lab protocol, but for most, the original vial is perfectly fine

Whether you're new to vitamin injections or continuing an existing routine, our providers take a conservative, evidence-informed approach and explain every step no pressure, just honest guidance and provider-led care